The Insider Edge: Three High-Potential Stocks for This Week

Market noise is relentless. Financial headlines scream about the same handful of stocks while important opportunities—the kind that can meaningfully impact your portfolio—often fly completely under the radar.

That’s exactly why we publish this watchlist each week.

While most investors are distracted by mainstream narratives, we’re digging through earnings transcripts, analyzing technical setups, and monitoring institutional money flows to identify companies at potential inflection points. Our focus isn’t on what’s already priced in, but rather on what the market hasn’t fully appreciated yet.

Each week, we spotlight three stocks that merit your attention. We focus on opportunities where timing, valuation, and catalysts align to create potentially favorable entry points.

Our rigorous analysis goes beyond surface-level metrics to identify opportunities that most retail investors don’t have time to uncover. Each pick comes with clear reasoning, specific triggers to watch for, and a compelling risk-reward profile designed to help you make more informed investment decisions.

Here’s what caught our eye this week:

Nvidia (NVDA)

Nvidia stands as the undisputed leader in the artificial intelligence revolution, maintaining its position as the primary barometer for the entire AI industry’s health and future prospects. As the semiconductor giant navigates the current “TACO trade” environment – where market volatility is driven by tariff policy announcements – its fundamental business strength remains intact while benefiting from massive ongoing infrastructure investments by technology titans. What makes Nvidia particularly compelling at current levels is its ability to maneuver around geopolitical headwinds while securing major new revenue streams, evidenced by recent multi-billion-dollar contracts in the UAE and Saudi Arabia for its latest Blackwell GPU systems.

The company’s strategic positioning becomes increasingly valuable as cloud hyperscalers Amazon, Microsoft, and Alphabet, along with tech giants like Meta Platforms and Apple, continue their aggressive buildout of AI data centers. This represents a multi-trillion-dollar investment opportunity where Nvidia’s high-performance GPUs serve as essential infrastructure components. Additionally, potential mega-deals such as Elon Musk’s xAI reportedly considering $40 billion in chip purchases demonstrate the scale of demand for Nvidia’s cutting-edge technology across both established enterprises and emerging AI-focused companies.

While export restrictions have limited Nvidia’s opportunities in China and created some near-term uncertainty, the company’s global market leadership and technological edge provide multiple pathways for continued growth. The stock’s current valuation appears reasonable compared to historical levels on a forward price-to-earnings basis, particularly considering the sustained demand visibility through the remainder of 2025. For investors seeking exposure to the AI infrastructure buildout with a company that has consistently demonstrated its ability to innovate and adapt to changing market conditions, Nvidia offers a compelling opportunity to participate in one of technology’s most transformative trends while benefiting from the company’s proven execution capabilities.

Brookfield Renewable (BEPC)

Brookfield Renewable has emerged as an exceptionally compelling dividend opportunity following a recent decline that has pushed shares more than 15% below their 52-week highs. Trading at around $29 per share, the renewable energy leader now offers an attractive dividend yield exceeding 5% – more than three times the S&P 500’s current yield of less than 1.5%. What makes this opportunity particularly attractive is Brookfield’s remarkable track record of growing its dividend at a 6% compound annual rate since 2001, with at least 5% increases in each of the past 14 years, backed by exceptionally stable cash flows from long-term power purchase agreements.

The company’s business model provides unusual income stability through approximately 90% of its power production being sold under long-term, fixed-rate contracts with an average remaining term of 14 years. Crucially, 70% of these contracts include inflation indexing, providing natural protection against rising costs while ensuring growing cash flows over time. This contractual foundation, combined with Brookfield’s investment-grade balance sheet, creates a defensive cash flow profile that supports both current dividend payments and future growth initiatives across multiple market cycles.

Looking ahead, Brookfield projects powerful growth drivers that should enable continued dividend increases at 5-9% annually. The company expects funds from operations per share to grow by more than 10% annually through 2030, driven by inflation-linked contract escalations (2-3% annually), higher rates on contract renewals (2-4% annually), and new capacity development (4-6% annually). With 8 gigawatts of new capacity commissioning this year and development capabilities ramping to 10 gigawatts annually by 2027, Brookfield offers investors the rare combination of a high current yield, reliable growth, and exposure to the accelerating global energy transition. For income-focused investors seeking both current yield and long-term appreciation potential, Brookfield’s current valuation represents an opportunity to secure total annual returns potentially exceeding 15%.

Berkshire Hathaway (BRK.B)

Berkshire Hathaway stands at a historic inflection point following Warren Buffett’s announcement that he will step down as CEO by year-end, with longtime executive Greg Abel taking the reins of the trillion-dollar conglomerate. Trading at around $504 per share, some investors may view this leadership transition with concern given Buffett’s legendary track record. What makes this transition particularly manageable is the robust and diversified business foundation Buffett leaves behind – including several dozen subsidiaries across multiple sectors, an impressive stock portfolio, and a massive cash stockpile that positions Berkshire to handle severe economic shocks better than most companies.

Abel’s succession represents a carefully orchestrated transition rather than an abrupt change, as he has spent years absorbing Buffett’s investment philosophy while capably overseeing a large portion of Berkshire’s operations. The incoming CEO won’t be operating in isolation either – many of Berkshire’s key executives have been with the company for decades and have contributed significantly to its achievement of trillion-dollar market capitalization status. This experienced management team, combined with Berkshire’s decentralized operating structure, should ensure business continuity during the leadership change.

Perhaps most importantly, Berkshire’s diversified business model provides natural resilience during periods of economic uncertainty. The conglomerate’s varied subsidiaries – spanning insurance, utilities, railroads, manufacturing, and retail – create a portfolio effect where some businesses may thrive while others face challenges, helping to smooth overall performance. This structural advantage becomes particularly valuable in the current environment of trade policy uncertainty and potential macroeconomic turbulence. For investors seeking a defensive yet growth-oriented position managed by a proven investment philosophy and experienced team, Berkshire’s current setup offers compelling long-term value creation potential even as it navigates this significant leadership transition.

The Exit Strategy: Stocks Showing Critical Warning Signs

May 31, 2025

Every successful investor knows a painful truth: knowing when to sell is often more critical than knowing what to buy.

While financial media overwhelmingly focuses on buying opportunities, our research consistently identifies companies facing significant headwinds that merit serious consideration for selling. These aren’t just stocks underperforming the market; they’re businesses confronting structural challenges, deteriorating fundamentals, or carrying valuations disconnected from financial reality.

What you won’t find here: reactionary calls based on short-term price movements or headline volatility. Each company on this list has been thoroughly analyzed across multiple metrics that historically precede substantial declines.

Smart investors understand that portfolio management requires both addition and subtraction. Sometimes the best investment decision is to redeploy capital away from troubling positions before problems fully materialize in the share price.

This week’s watchlist highlights stocks showing critical weaknesses that demand immediate attention:

Canopy Growth (CGC)

Canopy Growth’s catastrophic 21.64% Friday collapse following an earnings report that can only be described as disastrous demonstrates how quickly a struggling company can crater when fundamentals deteriorate beyond investor tolerance. The Canadian cannabis producer delivered a staggering $1.32 per share loss versus analyst expectations of just $0.20 – a miss of over 500% that sent shockwaves through an already beleaguered sector. This massive disappointment came alongside declining global sales (down 11% in Q4) and persistent negative free cash flow of $36.2 million for the quarter, bringing full-year FCF to negative $176.6 million.

What makes Canopy’s situation particularly concerning is the company’s inability to find any sustainable growth trajectory despite years of restructuring efforts. While management attempted to highlight 4% Canadian sales growth and 13% medical cannabis growth, these modest gains pale in comparison to the 9% full-year revenue decline and accelerating losses. Trading at just $1.34, down from a 52-week high of $8.84, the stock has lost 85% of its value in a year while maintaining a precarious $308 million market capitalization that appears increasingly difficult to justify given the company’s cash burn rate.

The extraordinary trading volume of 13.3 million shares versus the 7.2 million average suggests institutional investors are abandoning positions en masse. Despite management’s promises of eventual positive EBITDA and free cash flow, the trajectory appears to be moving in the opposite direction with accelerating quarterly losses. With a razor-thin 21.33% gross margin providing minimal cushion against further deterioration and no dividend to support the share price, Canopy Growth represents a classic value trap where each earnings report risks triggering additional selling pressure. For investors still holding positions, the combination of structural industry challenges and company-specific execution failures presents a compelling case for immediate exit before the next potential leg down.

Tempus AI (TEM)

Tempus AI faces a credibility crisis following a damning short-seller report from Spruce Point Capital Management that triggered a 13.2% weekly decline and raised fundamental questions about the company’s business practices and financial reporting. The healthcare AI company, which had already suffered a 4% decline the previous week, now confronts serious allegations regarding the integrity of founder Eric Lefkofsky, questionable financial reporting practices, and concerns about the legitimacy of its partnership with AstraZeneca. Spruce Point’s analysis suggests the stock could fall 50-60% from its pre-report levels, implying a target price range of $26.35 to $32.94.

The timing of these allegations is particularly problematic for a company trading at elevated valuations in an increasingly skeptical market environment. At $53.72, down from recent highs but still commanding a $9 billion market capitalization, Tempus AI’s valuation appears vulnerable if the short-seller’s claims gain traction or trigger regulatory scrutiny. The healthcare AI sector has already faced increased investor skepticism about growth prospects and actual revenue-generating capabilities, making companies in this space particularly susceptible to credibility attacks.

While short-seller reports should always be evaluated critically rather than accepted at face value, the specific nature of Spruce Point’s allegations regarding financial reporting and business partnerships creates significant uncertainty for Tempus AI’s near-term prospects. The firm’s track record in identifying problematic situations in the investment management space adds weight to their analysis. With the stock already showing technical weakness and facing potential regulatory or partnership disruptions if the allegations prove substantive, investors should carefully consider whether the risk-reward profile remains attractive. The combination of elevated valuations, credibility questions, and a challenging operating environment for healthcare AI companies suggests a cautious approach is warranted until these issues are resolved.

Cava Group (CAVA)

Cava Group exemplifies the market’s growing intolerance for extreme valuations, even when underlying business performance remains strong. Despite crushing first-quarter expectations with robust double-digit revenue and profitability growth alongside encouraging customer traffic increases, the Mediterranean restaurant chain’s shares declined nearly 13% for the week as investors finally questioned whether the stock’s premium multiples remain sustainable. Trading at a forward P/E ratio of nearly 141 and a price-to-sales ratio approaching 10, Cava’s valuation appears increasingly disconnected from reality when compared to established restaurant operators like Chipotle, which trades at far more reasonable multiples of 42x earnings and 6x sales.

The market’s negative reaction to what should have been celebrated results signals a fundamental shift in investor sentiment toward growth stocks trading at extreme premiums. At $79.68, down from its 52-week high of $172.43, Cava has already experienced significant volatility, yet the current $9 billion market capitalization still appears to price in flawless execution and unlimited growth potential. While the company’s 18.97% gross margin and cautious expansion strategy demonstrate operational discipline, these positives may not be sufficient to justify such extreme valuations in an environment where investors are increasingly focused on valuation metrics.

The concerning aspect of Cava’s recent decline is that it occurred despite strong operational performance, suggesting that even perfect execution may not be enough to support the current share price. Management’s slightly declining restaurant-level profit margins, while not alarming in isolation, become more significant when the stock trades at such elevated multiples that leave no room for disappointment. For investors holding positions, the combination of extreme valuations and growing market skepticism toward premium-priced growth stocks suggests this may be an opportune time to take profits before a potentially more significant correction materializes. While Cava’s long-term prospects may remain intact, the near-term risk-reward profile appears increasingly unfavorable at current valuation levels.

Bottom Line

This week’s featured companies illustrate three distinct types of investment risks that can quickly erode shareholder value: fundamental business deterioration (Canopy Growth), credibility concerns from short-seller attacks (Tempus AI), and unsustainable valuations even amid strong performance (Cava Group). In each case, the market’s reaction suggests investors are becoming more discriminating about risk factors that might have been overlooked during more optimistic periods. Whether facing operational challenges, governance questions, or valuation concerns, these stocks demonstrate how quickly sentiment can shift when underlying vulnerabilities are exposed. For prudent investors, these developments serve as reminders that protecting capital often requires making difficult decisions before problems fully materialize in long-term performance.

AI Infrastructure Watchlist: 3 Critical Picks-and-Shovel Plays Powering the Next Wave of Tech

Not every big winner in the AI boom will come from flashy chatbots or headline-grabbing startups. Some of the most reliable opportunities are hiding in plain sight—in companies supplying the infrastructure that every AI application depends on.

These are the “picks-and-shovels” of the AI gold rush. Whether it’s powering cloud workloads, manufacturing next-gen chips, or enabling quantum breakthroughs, these businesses are positioned to benefit no matter which specific applications take the lead.

Here are three stocks we’re watching right now:

Amazon (NASDAQ: AMZN) – AWS Is Quietly Becoming the Profit Engine of the AI Era

While most investors still associate Amazon with e-commerce, the real growth story is Amazon Web Services (AWS). At $206 per share, Amazon’s cloud division is responsible for 63% of total operating income—despite only accounting for 19% of revenue.

AWS is growing 17% year-over-year with operating margins near 39%, far outpacing the retail segment. Two major trends are pushing this growth: the long-term shift from on-premises to cloud, and the explosion in demand for AI training infrastructure. Companies don’t want to build expensive in-house setups—and AWS is where they go instead.

With the global cloud market expected to triple by 2030, Amazon’s dominance in this space is becoming harder to ignore. For investors, it may be time to reevaluate Amazon through the lens of operating income—not top-line growth diluted by legacy segments.

IonQ (NYSE: IONQ) – The Only Quantum Player Integrated Across All Major Cloud Platforms

IonQ is the standout name in quantum computing, thanks to its proprietary trapped-ion technology and a growing list of high-profile partnerships. Currently trading around $35 with a $9B market cap, it’s the only quantum hardware provider available on AWS, Azure, and Google Cloud.

That cloud accessibility—and strong strategic backing from firms like Nvidia, Toyota Tsusho, and General Dynamics—positions IonQ at the heart of the next major computing shift. The company is already generating revenue with its Forte Enterprise system and is targeting an $87B total addressable market by 2035.

Quantum may feel futuristic, but IonQ is turning theory into traction. For investors looking to gain exposure early, this is one of the few publicly traded names with both real revenue and unmatched access to cloud infrastructure.

Taiwan Semiconductor (NYSE: TSM) – The Backbone of AI Chip Production

No AI model runs without advanced chips—and Taiwan Semiconductor (TSM) is where most of them get made. At ~$194, TSM controls roughly 67% of the global contract chip manufacturing market and posted a 42% year-over-year revenue gain in Q1 2025.

TSM produces chips for Apple, Nvidia, and Qualcomm, and even Intel now relies on them for leading-edge designs. With $40 billion in planned 2025 capex—including expanded capacity in the U.S.—the company is investing heavily to keep up with demand and reduce geopolitical risk.

Despite its dominance and 47% year-over-year income growth last quarter, the stock trades at just 25x earnings. For a company powering nearly every major AI breakthrough, that’s an attractive valuation.

Bottom Line:
These three companies aren’t betting on which AI app wins—they’re building the roads and bridges everyone needs to get there. That’s why we’re watching them closely.

The Insider Edge: Three High-Potential Stocks for This Week

Market noise is relentless. Financial headlines scream about the same handful of stocks while important opportunities—the kind that can meaningfully impact your portfolio—often fly completely under the radar.

That’s exactly why we publish this watchlist each week.

While most investors are distracted by mainstream narratives, we’re digging through earnings transcripts, analyzing technical setups, and monitoring institutional money flows to identify companies at potential inflection points. Our focus isn’t on what’s already priced in, but rather on what the market hasn’t fully appreciated yet.

Each week, we spotlight three stocks that merit your attention. We focus on opportunities where timing, valuation, and catalysts align to create potentially favorable entry points.

Our rigorous analysis goes beyond surface-level metrics to identify opportunities that most retail investors don’t have time to uncover. Each pick comes with clear reasoning, specific triggers to watch for, and a compelling risk-reward profile designed to help you make more informed investment decisions.

Here’s what caught our eye this week:

Sea Limited (SE)

Sea Limited has executed a remarkable business turnaround after experiencing significant challenges post-pandemic, with all three of its core segments now demonstrating renewed growth momentum. Trading at around $165 per share, the Singapore-based conglomerate has already delivered over 120% returns in the past 12 months but remains 56% below its 2021 all-time highs. What makes Sea particularly compelling at current levels is the synchronized recovery across its gaming (Garena), e-commerce (Shopee), and fintech (Monee) divisions, with Q1 2025 revenue surging 30% year-over-year to $4.8 billion while the company returned to profitability with $411 million in net income.

The company’s strategic course corrections have addressed previous missteps while positioning each segment for sustained growth. Garena’s gaming revenue has stabilized and grown 8% quarterly as Free Fire experiences a resurgence, with potential upside from the game’s eventual return to the Indian market. Shopee has wisely refocused on Southeast Asian markets where it maintains competitive advantages, abandoning costly expansion attempts in Europe and Latin America while investing in logistics infrastructure to strengthen its market position against competitors like TikTok. Meanwhile, Monee continues its explosive growth trajectory with 58% quarterly revenue expansion, serving underbanked customers while benefiting from network effects across Sea’s ecosystem.

Despite impressive recent performance, Sea’s valuation metrics suggest continued upside potential. While the trailing P/E ratio of 115 appears elevated, the forward P/E of 41 reflects expected earnings growth as the company’s operational improvements translate to improved profitability. The company’s Amazon-like business model in Southeast Asia – combining e-commerce, fintech, and entertainment – creates powerful synergies and network effects that should drive long-term value creation. For investors seeking exposure to Southeast Asia’s digital transformation with a proven management team that has successfully navigated significant challenges, Sea Limited offers an attractive risk-reward profile as it approaches full recovery from its earlier setbacks.

Celsius Holdings (CELH)

Celsius Holdings has formed what technical analysts characterize as a classic “bearish-to-bullish reversal” pattern after establishing a solid base following its significant decline from previous highs. The energy drink company’s recent price action suggests a fundamental shift from the established downtrend that has pressured shares over recent quarters. What makes this technical setup particularly compelling is the combination of a rounding bottom formation with improving accumulation patterns, suggesting institutional investors may be quietly building positions ahead of a potential breakout that could target $10 higher from current levels.

The beverage company’s positioning in the rapidly growing energy drink market provides fundamental support for the technical reversal thesis. Despite facing headwinds from increased competition and market saturation concerns that contributed to the stock’s previous decline, Celsius has maintained its differentiated product positioning focused on healthier energy alternatives. The company’s distribution partnerships and brand recognition within the fitness and active lifestyle segments create defensive characteristics that should support a sustained recovery as consumer spending patterns normalize.

From a risk-reward perspective, the current setup offers an attractive entry point for investors willing to embrace the early stages of what could be a significant trend reversal. Technical analysis suggests the stock has completed its basing process and begun forming higher lows – a critical component of trend change confirmation. While beverage stocks face ongoing challenges from ingredient cost inflation and competitive pressures, Celsius’s established market position and the constructive technical pattern suggest the worst of the selling pressure may be behind the company. For traders and investors comfortable with moderate volatility, the current price level represents an opportunity to participate in a potential recovery story backed by both technical and fundamental catalysts.

Target (TGT)

Target represents a compelling recovery opportunity for investors seeking exposure to retail resilience combined with an attractive dividend yield. Trading at around $94 per share, the retailer has faced near-term headwinds including a 2.8% decline in net sales during the most recent quarter amid challenging consumer spending conditions. What makes Target particularly attractive at current levels is its exceptional valuation of just 11 times forward earnings combined with a robust 4.8% dividend yield – four times higher than the S&P 500’s 1.2% yield – while maintaining its prestigious Dividend King status with over 50 consecutive years of dividend increases.

Despite recent sales challenges, Target has demonstrated remarkable structural resilience by successfully retaining the substantial market share gains achieved during the pandemic’s early stages. The company added more than $30 billion in revenue during that period and has maintained these gains even as shopping patterns normalized, indicating permanent market share capture rather than temporary pandemic benefits. Furthermore, Target’s digital transformation continues advancing with 4.7% growth in digital comparable sales even during the challenging recent quarter, while the newly established Enterprise Acceleration Office focuses on driving operational efficiency improvements.

Target’s strategic advantages extend beyond its current operational metrics through its portfolio of over 40 owned brands, with one-quarter achieving billion-dollar business status. These proprietary brands provide superior gross margins compared to national brands while offering Target greater pricing control and differentiation from competitors. Combined with the company’s focus on supply chain optimization and digital integration, these owned brands create sustainable competitive advantages that should drive margin expansion as economic conditions improve. For income-focused investors seeking both defensive characteristics and recovery potential, Target’s combination of attractive valuation, superior dividend yield, and structural competitive advantages creates a compelling risk-reward profile at current price levels.

Three High-Growth Stocks Under $50 That Could Double Your Money

In a market that often focuses on mega-cap tech names, some of the most compelling growth opportunities can be found in smaller, less-followed companies with significant upside potential. While these investments typically come with higher volatility, they also offer the possibility of outsized returns for investors willing to accept additional risk.

We’ve identified three growth stocks trading under $50 per share that possess the fundamental catalysts and market positioning to potentially double investors’ money. These companies operate in high-growth sectors with substantial addressable markets and clear paths to expansion.

Applied Digital (APLD)

At around $7 per share and a modest $2 billion market cap, Applied Digital offers investors direct exposure to the explosive growth in AI data center infrastructure without the premium valuations of larger tech companies. The company specializes in designing, building, and operating data centers supporting artificial intelligence, blockchain, and high-performance computing applications.

What makes Applied Digital particularly compelling is its strategic location advantage. The company operates custom-built data centers in North Dakota, where energy capacity is abundant, electricity costs are low, and the cold climate provides natural cooling—critical advantages in an industry where power consumption and cooling represent major operational expenses.

Despite rallying nearly 60% over the past twelve months, Applied Digital remains approximately 50% below its February 2025 peak of around $12.50. This presents a realistic path to doubling from current levels if the company can execute on its growth strategy and benefit from the sustained demand for AI computing infrastructure.

The company recently announced a strategic decision to divest its cloud services business, which should provide additional capital to invest in its higher-growth AI and high-performance computing segments. This focus on the most promising areas of data center demand, combined with recent financing deals, positions Applied Digital to capitalize on the AI infrastructure buildout that shows no signs of slowing.

While certainly not without risk, Applied Digital’s specialized focus on next-generation computing infrastructure at a time of unprecedented demand growth creates a compelling opportunity for investors looking for direct exposure to the physical backbone of the AI revolution.

IonQ (IONQ)

For investors seeking exposure to the next potential computing breakthrough, IonQ offers a pure-play investment in quantum computing technology. Trading around $35 per share with an $8-9 billion market cap, this pioneering company is commercializing quantum systems that could fundamentally transform industries ranging from cryptography to drug discovery and financial modeling.

What separates IonQ from other quantum computing initiatives is its trapped-ion architecture, which the company claims delivers superior performance and error correction capabilities compared to competing approaches. This technological differentiation has helped IonQ secure partnerships with all three major cloud providers—Amazon Web Services, Microsoft Azure, and Google Cloud—making it the only quantum hardware available across all major cloud platforms.

The company’s impressive partner roster extends beyond cloud providers to include SK Telecom, Toyota Tsusho, General Dynamics, and Nvidia. These relationships not only validate IonQ’s technology but also provide multiple commercialization pathways as quantum computing transitions from research curiosity to practical business applications.

IonQ estimates its total addressable market could reach $87 billion by 2035, suggesting enormous growth potential from its current valuation if it can maintain its technological leadership position. While quantum computing comes with unique technical challenges and commercialization uncertainties, IonQ’s first-mover advantage and partnerships with tech giants create a credible path to significant share price appreciation for patient investors.

Summit Therapeutics (SMMT)

Summit Therapeutics offers investors exposure to a potentially transformative cancer treatment at a relatively accessible price point of around $24 per share. Despite its larger $17+ billion market cap, Summit represents a compelling growth opportunity based on the potential of its lead asset ivonescimab, a novel cancer immunotherapy currently in late-stage clinical trials.

The company’s growth thesis centers on ivonescimab’s potential in non-small cell lung cancer (NSCLC), with mid-2025 data readouts expected from an important phase 3 trial evaluating the therapy in combination with chemotherapy. What makes Summit particularly interesting is that its partner Akeso has already secured two regulatory approvals for ivonescimab in China after the drug demonstrated superiority to Merck’s blockbuster Keytruda in a head-to-head clinical trial.

This existing regulatory validation in China significantly de-risks Summit’s clinical program and suggests a higher probability of success in securing FDA approval than typical late-stage oncology candidates. If ivonescimab can replicate these impressive results in U.S. studies, it could challenge established players in the multi-billion-dollar cancer immunotherapy market.

Beyond its initial lung cancer indication, Summit is expanding ivonescimab’s development into additional cancer types including cutaneous squamous cell carcinoma and glioblastoma. This pipeline expansion creates multiple pathways to growth and could substantially increase the drug’s commercial potential over time.

While biotech investments always carry clinical and regulatory risks, Summit’s combination of late-stage assets, existing regulatory validation in international markets, and multiple cancer indications in development creates a risk-reward profile that could reward investors with significant upside if ivonescimab successfully navigates the approval process.

Bottom Line

Applied Digital, IonQ, and Summit Therapeutics represent three distinct approaches to high-growth investing across technology infrastructure, quantum computing, and biotechnology. While each company faces its own set of challenges and competitive pressures, all three share a common thread: significant market opportunities, differentiated positioning, and reasonable valuations relative to their growth potential.

For investors willing to accept higher volatility in exchange for the possibility of outsized returns, allocating a portion of a diversified portfolio to these types of growth opportunities can be a sensible strategy. With share prices under $50, these stocks also offer accessibility to investors working with more modest initial capital.

As with any high-growth investment, position sizing is critical—these companies should represent speculative allocations rather than core holdings for most investors. However, for those seeking exposure to potentially transformative technologies and treatments with the possibility of doubling their investment, these three stocks merit consideration as part of a balanced growth portfolio.

Congress Is Buying These 4 Stocks — Should you? 

There’s been growing momentum in Congress to ban stock trading by U.S. lawmakers — but for now, we still get a rare glimpse into what some elected officials are adding to their portfolios. Recent disclosures show members of Congress buying into four heavyweight stocks that also happen to be longtime Warren Buffett holdings. While the headlines focus on the political angle, we think there are strong business reasons these names are worth attention — regardless of who’s buying.

Here’s a closer look at why these stocks deserve a spot on your radar for the months ahead.

Amazon (AMZN): Cloud Strength and AI Tailwinds Keep This Giant Attractive

Amazon (NASDAQ: AMZN) has been a bipartisan favorite in Congress recently, with Rep. Dwight Evans (D-PA) and Rep. Marjorie Taylor Greene (R-GA) both adding shares in April. And it’s easy to see why. Amazon is still dominant in e-commerce, but the bigger story is its cloud division, Amazon Web Services, which continues to benefit from booming demand for artificial intelligence infrastructure.

Importantly, Amazon’s trailing 12-month price-to-earnings ratio is sitting near its lowest levels since the 2007–2009 financial crisis, offering a rare valuation reset for a company of this size. While a recession could pressure near-term results, we think Amazon’s long-term growth in both retail and cloud is intact. For patient investors, this could be a great moment to build or add to a position.

American Express (AXP): A Solid Bet on Consumer and Corporate Spending

Rep. Rick Larsen (D-WA) was the only congressional buyer of American Express (NYSE: AXP) stock in recent weeks, purchasing shares on April 8. AmEx is a core Berkshire Hathaway holding, valued at over $40 billion, and despite a roughly 10% year-to-date pullback tied to market jitters over tariffs, the company’s fundamentals remain strong.

AmEx continues to post steady revenue and earnings growth, with management expecting a solid performance for the full year despite macro headwinds. We view this as a high-quality financial name with strong brand power, resilient customer loyalty, and attractive long-term potential, especially when bought on a dip.

Apple (AAPL): A Discounted Opportunity in a Global Leader

Apple (NASDAQ: AAPL) has been under pressure, falling about 18% from its highs — but that hasn’t scared off Congress. In late March and April, Reps. Jefferson Shreve (R-IN), Marjorie Taylor Greene (R-GA), and Rob Bresnahan (R-PA) all picked up shares.

We see a compelling long-term case for Apple despite near-term concerns about tariffs and slowing iPhone sales growth. Apple’s ecosystem — anchored by the iPhone but now extending into services, wearables, and potentially new product categories — remains a powerhouse. While short-term traders may hesitate, long-term investors looking for a cash-rich tech leader with a history of innovation should keep Apple on their watchlist.

Berkshire Hathaway (BRK.B): Diversified Strength With Dry Powder Ready

Rep. Marjorie Taylor Greene also added shares of Berkshire Hathaway (NYSE: BRK.B) to her portfolio, and there’s a lot to like here. The stock has been a relative winner in 2025, outperforming major indexes and benefiting from Buffett’s legendary cash discipline. With over $334 billion in cash on hand, Berkshire is well-positioned to take advantage of market dislocations if valuations become more attractive.

Interestingly, Berkshire paused share buybacks in Q4 2024 — a potential signal the stock is trading closer to fair value. Even so, we think Berkshire remains a compelling option for investors seeking an exceptionally managed, diversified portfolio of businesses and public equities. This is a name you buy for stability and long-term compounding, not just because a congresswoman did.

Congress’ buying activity can be interesting to watch, but the real reason to pay attention to these stocks is their long-term fundamentals. Amazon, American Express, Apple, and Berkshire Hathaway each bring a mix of market leadership, resilience, and growth potential — and that’s a portfolio lineup worth watching closely.

Three Smart Ways to Play the Emerging Markets Rebound

Emerging markets have been out of favor for years—but that may finally be changing. JPMorgan just upgraded its outlook on emerging market equities from neutral to overweight, citing easing U.S.-China trade tensions, a softer U.S. dollar, and compelling relative valuations. With global headlines shifting and valuations still well below historical averages, investors might finally have a window to re-enter the space.

Year-to-date, the MSCI Emerging Markets Index is up 9%, already outperforming the S&P 500’s 1.3% gain. That momentum is also starting to show up in specific regions, particularly India and Brazil, which have seen strong equity inflows and outperformance so far this year.

Below are three ways to get diversified or targeted exposure to the space—each with a slightly different angle, depending on your risk appetite and focus.

iShares MSCI Emerging Markets ETF (EEM) – Broad Exposure With Renewed Momentum

If you’re looking for one-click exposure to a basket of emerging market equities, EEM is still one of the best tools out there. It provides access to large- and mid-cap companies across more than 20 developing countries.

Trading around $46, the ETF has posted a 10.6% gain so far in 2025—on pace for its best year since 2020. China’s market stabilization, combined with easing trade tensions, has been a key catalyst for the recent move. For investors looking to participate in the rebound without trying to pick winners, EEM remains a solid core holding.

iShares MSCI India ETF (INDA) – Targeted Exposure to a Fast-Growing Giant

India’s economic engine keeps gaining traction, and that growth is starting to show up in market returns. INDA gives investors access to large and mid-cap Indian equities, with financials, IT, and consumer stocks making up the bulk of the portfolio.

The ETF is currently trading near $55 and has posted a modest but steady 4% year-to-date gain. With a favorable demographic profile, growing consumer market, and expanding tech footprint, India is well-positioned to deliver long-term returns—and INDA offers a straightforward way to get in.

iShares MSCI Brazil ETF (EWZ) – Riding the Upside of Commodity and Policy Tailwinds

Brazil has quietly become one of the standout performers in emerging markets this year. EWZ, which tracks major Brazilian equities, is up 24% year-to-date—easily outpacing peers.

At $28 per share, the ETF is benefiting from both macro and micro tailwinds: stable inflation, strong commodity exports, and domestic policy stability. Financials and materials are heavily weighted here, making EWZ a compelling option for those looking to benefit from global demand for raw materials and infrastructure investment.


Emerging markets finally have a setup that looks favorable across both fundamentals and technicals. Whether you’re looking for broad exposure or more focused plays, now could be a smart time to revisit the sector.

The Insider Edge: Three High-Potential Stocks for This Week

Market noise is relentless. Financial headlines scream about the same handful of stocks while important opportunities—the kind that can meaningfully impact your portfolio—often fly completely under the radar.

That’s exactly why we publish this watchlist each week.

While most investors are distracted by mainstream narratives, we’re digging through earnings transcripts, analyzing technical setups, and monitoring institutional money flows to identify companies at potential inflection points. Our focus isn’t on what’s already priced in, but rather on what the market hasn’t fully appreciated yet.

Each week, we spotlight three stocks that merit your attention. We focus on opportunities where timing, valuation, and catalysts align to create potentially favorable entry points.

Our rigorous analysis goes beyond surface-level metrics to identify opportunities that most retail investors don’t have time to uncover. Each pick comes with clear reasoning, specific triggers to watch for, and a compelling risk-reward profile designed to help you make more informed investment decisions.

Here’s what caught our eye this week:

Amazon (AMZN)

Amazon’s true value proposition for investors has fundamentally shifted from its well-known e-commerce operations to its cloud computing dominance. Trading at around $206 per share, the company’s Amazon Web Services (AWS) division now accounts for a remarkable 63% of total operating profits despite generating only 19% of overall revenue. What makes this dynamic particularly compelling is AWS’s superior financial profile – delivering 17% year-over-year revenue growth with an impressive 39% operating margin, far outpacing the North American e-commerce segment’s 8% growth and modest 6.3% margin.

The cloud computing segment stands at a critical inflection point driven by two powerful growth catalysts. First, the ongoing migration of enterprise computing resources from on-premises infrastructure to cloud environments represents a multi-year tailwind that should persist for at least another decade. Second, the artificial intelligence revolution has created significant new demand for cloud computing resources as companies seek to train proprietary AI models without investing in expensive dedicated hardware. These dual growth drivers have positioned the global cloud computing market for explosive expansion, with industry research projecting growth from approximately $750 billion in 2024 to $2.3 trillion by 2030.

For investors, this structural shift in Amazon’s profit engine necessitates a fundamental reframing of how to evaluate the company’s performance. Rather than focusing solely on top-line revenue growth, which is diluted by the mature e-commerce segments, attention should center on operating profit growth – which has substantially outpaced revenue expansion in recent quarters. Perhaps most attractive from an investment perspective is AWS’s insulation from tariff concerns that have impacted many other technology companies with significant overseas manufacturing dependencies. As cloud computing becomes an increasingly critical component of global business infrastructure, Amazon’s leadership position through AWS creates a compelling investment case that extends well beyond its e-commerce roots.

IonQ (IONQ)

IonQ has emerged as a frontrunner in the quantum computing race, establishing strategic partnerships with technology giants while maintaining a technological edge through its proprietary trapped-ion architecture. Trading at around $35 per share with a market capitalization of approximately $9 billion, the quantum computing pioneer has positioned itself at the center of what could be the next major computing paradigm shift. What makes IonQ particularly compelling is its unique distinction as the only quantum hardware provider available across all three major cloud platforms – Amazon Web Services, Microsoft Azure, and Google Cloud – giving it unparalleled market access while validating its technological approach.

The company’s trapped-ion quantum architecture offers distinct advantages over competing approaches, delivering faster processing capabilities with a more scalable error correction process that requires the lowest overhead in the industry. This technological edge has attracted an impressive roster of strategic partners spanning multiple sectors: South Korean telecommunications leader SK Telecom, Japanese conglomerate Toyota Tsusho, U.S. defense contractor General Dynamics, and semiconductor powerhouse Nvidia. These partnerships not only validate IonQ’s technology but also create multiple commercialization pathways across diverse industries and geographies.

While quantum computing is often viewed as a future technology, IonQ is already generating revenue through its Forte Enterprise system while targeting a projected addressable market of $87 billion by 2035. The technology’s potential applications span critical fields including encryption, drug discovery, and financial modeling – areas where quantum advantages over classical computing could create substantial economic value. For investors seeking exposure to the quantum computing revolution with a company that has demonstrated both technological leadership and commercial traction, IonQ presents a unique opportunity to participate in what may become one of the most transformative computing advances of the next decade.

Taiwan Semiconductor (TSM)

Taiwan Semiconductor has solidified its position as the critical infrastructure provider powering the artificial intelligence revolution, with its dominance in advanced chip manufacturing creating a virtually unmatchable competitive moat. Trading at around $194 per share, the world’s leading semiconductor foundry has captured an impressive 67% market share in the contract manufacturing space as of late 2024. What makes TSM particularly attractive at current levels is the combination of its rapid growth trajectory – with Q1 2025 revenue surging 42% year-over-year to almost $26 billion – and a relatively modest valuation multiple of 25 times earnings despite its market-leading position and technological edge.

The company’s technological leadership has become so pronounced that even Intel, which historically manufactured its own chips, now relies on TSM for its most advanced designs. This technological superiority has made TSM the favored manufacturing partner for the AI ecosystem’s most critical companies including Nvidia, Apple, and Qualcomm. The company isn’t resting on its achievements either – it plans approximately $40 billion in capital expenditures for 2025 to expand production capacity and meet surging demand for advanced semiconductor solutions. This includes strategic investments in Arizona facilities that address geopolitical concerns by diversifying manufacturing beyond Taiwan.

Looking ahead, TSM stands to benefit from two significant tailwinds: overall semiconductor industry growth projected at 8% CAGR through 2030, and the explosion in AI chip demand estimated at a 29% CAGR over the same period. With comprehensive income increasing 47% in the first quarter of 2025 to nearly $12 billion as operating expenses grew more slowly than revenue, TSM’s operating leverage creates a powerful earnings growth dynamic. Despite geopolitical tensions that have sometimes pressured the stock, the company’s indispensable position in advanced chip manufacturing – particularly for AI applications – combined with its reasonable valuation creates a compelling opportunity for investors seeking exposure to the semiconductor industry’s most critical enabler.

The Exit Strategy: Stocks Showing Critical Warning Signs

May 17, 2025

Every successful investor knows a painful truth: knowing when to sell is often more critical than knowing what to buy.

While financial media overwhelmingly focuses on buying opportunities, our research consistently identifies companies facing significant headwinds that merit serious consideration for selling. These aren’t just stocks underperforming the market; they’re businesses confronting structural challenges, deteriorating fundamentals, or carrying valuations disconnected from financial reality.

What you won’t find here: reactionary calls based on short-term price movements or headline volatility. Each company on this list has been thoroughly analyzed across multiple metrics that historically precede substantial declines.

Smart investors understand that portfolio management requires both addition and subtraction. Sometimes the best investment decision is to redeploy capital away from troubling positions before problems fully materialize in the share price.

This week’s watchlist highlights stocks showing critical weaknesses that demand immediate attention:

UnitedHealth Group (UNH)

UnitedHealth Group faces a potentially existential crisis as the Department of Justice’s healthcare fraud unit conducts a criminal investigation into possible Medicare fraud – a development that sent shares plummeting 19.2% in early Thursday trading before recovering slightly. This criminal probe comes on top of an existing civil fraud investigation and follows the abrupt departure of CEO Andrew Witty for “personal reasons” just days earlier. The confluence of these events creates a perfect storm of governance, legal, and operational concerns that has obliterated shareholder confidence in what was once considered a blue-chip healthcare company.

The magnitude of UnitedHealth’s market value destruction is historic – shares have collapsed 50% in just 23 trading days, the most severe drop for an S&P 100 company since Netflix’s 54% decline in May 2022. Now trading at $291.30, down from a 52-week high of $630.73, UNH has shed approximately $265 billion in market capitalization during this freefall. Perhaps most telling is the explosion in trading volume to 71.1 million shares versus the 11.3 million average, indicating widespread institutional abandonment of positions.

Beyond the legal investigations, UnitedHealth faces mounting operational challenges including rising healthcare costs that are pressuring margins, which recently forced the company to cut its full-year guidance. The 2.88% dividend yield provides minimal compensation for the extraordinary legal, regulatory, and business risks now facing the company. While UnitedHealth remains a massive enterprise with significant resources, history suggests that healthcare companies facing fraud investigations often experience protracted periods of underperformance as legal proceedings unfold over years rather than months. For investors who still view this as a temporary setback, the unprecedented speed and severity of the decline combined with the open-ended nature of criminal investigations presents a compelling case for moving to the sidelines until greater clarity emerges.

New Fortress Energy (NFE)

New Fortress Energy exemplifies a company approaching potential financial collapse as staggering losses force desperate asset sales to stave off insolvency. The LNG company’s 62.6% single-day implosion followed a catastrophic earnings report showing a $0.73 per share loss versus the expected $0.05 loss. Management’s attempt to highlight “one-time events” that might boost future earnings rang hollow given the company’s inability to source LNG at viable prices for its Latin American power operations – a fundamental problem with its business model rather than a temporary setback.

The company’s last-ditch attempt to remain afloat involves selling its Jamaican LNG import terminal, offshore floating storage, and other assets to Excelerate Energy for approximately $1 billion, with $325 million earmarked for debt reduction. However, this measure appears woefully inadequate given New Fortress’s staggering $9 billion debt burden (net of cash) and catastrophic $3.2 billion annual cash burn rate. Despite posting occasional GAAP profits, the company has never generated positive free cash flow in its history, suggesting a fundamentally flawed business model.

Now trading at just $2.63, down from a 52-week high of $27.65, New Fortress’s market capitalization has collapsed to just $729 million – less than 10% of its debt load. The extraordinary trading volume of 40.6 million shares versus the 9.2 million average reflects institutional panic selling. While the 30.29% gross margin and 3.76% dividend yield might appear attractive on paper, these metrics become irrelevant in the face of potentially terminal financial distress. With insufficient asset sales to meaningfully address its debt and no path to sustainable free cash flow, New Fortress appears to be entering a death spiral where each quarter brings the company closer to potential restructuring. For investors still holding positions, the window for orderly exits may be rapidly closing.

Luminar Technologies (LAZR)

Luminar Technologies demonstrates how quickly corporate governance issues can devastate a company’s market value and future prospects. The lidar manufacturer’s shares tumbled 17.6% following the abrupt resignation of founder, chairman, and CEO Austin Russell “following a code of business conduct and ethics inquiry” by the board’s audit committee. While the company emphasized that the matter does not impact financial results, the sudden removal of the visionary behind the company’s products and strategy creates an enormous leadership vacuum that may prove impossible to fill adequately.

The timing of this leadership crisis could hardly be worse for Luminar. The company is burning cash at an alarming rate while operating with negative gross margins of -34.07%, suggesting fundamental problems with its business model even before losing its chief strategist. Now trading at $4.72, down from a 52-week high of $32.70, Luminar’s market capitalization has shrunk to just $214 million – a valuation that provides minimal cushion against operating losses while the new leadership team gets up to speed.

Compounding these internal challenges, the broader automotive industry – Luminar’s target market – is reducing spending amid uncertainty about the Trump administration’s tariff plans. The combination of corporate governance issues, negative gross margins, and deteriorating end markets creates a perfect storm for a company already in a precarious financial position. With trading volume at 4.8 million shares versus the 2.5 million average, institutional investors appear to be heading for the exits. Given the numerous uncertainties now facing Luminar without its founder at the helm, investors should strongly consider whether the risk-reward profile still makes sense for their portfolios.

Bottom Line

This week’s featured companies represent particularly severe examples of how quickly corporate fortunes can deteriorate when multiple negative factors converge. UnitedHealth faces the specter of criminal fraud investigations while grappling with rising healthcare costs, New Fortress Energy confronts an unsustainable debt load that asset sales can’t fix, and Luminar Technologies must navigate a leadership crisis amid challenging market conditions. In each case, the dramatic price declines and extraordinary trading volumes suggest institutional investors are rapidly reassessing risk exposures. For retail investors still holding these positions, these dramatic moves should serve as serious warning signs that warrant immediate reconsideration before potential additional downside materializes.

Three Undervalued Giants to Buy Before They Recover

Market volatility often creates disconnects between stock prices and business fundamentals. While many investors instinctively avoid falling stocks, these temporary declines can create exceptional entry points for quality businesses with solid long-term prospects.

Our analysis identifies three market leaders currently trading near 52-week lows with compelling valuation metrics. Each faces short-term challenges that have pressured share prices, creating potential opportunities for investors willing to look beyond immediate headwinds.

Merck (MRK): Pharmaceutical Value With Pipeline Potential

Merck has experienced a punishing 22% decline year-to-date, recently touching fresh 52-week lows. This significant pullback reflects several near-term concerns, including recent quarterly results showing a 2% revenue decline and uncertainty surrounding tariff impacts on its global business.

The pharmaceutical giant specifically cited anticipated costs of approximately $200 million related to tariffs this year, with particular exposure to China – a key market for the company. However, recent diplomatic developments suggest potential relief, with both the U.S. and China agreeing to significantly reduce tariff rates for a 90-day period.

Beyond these short-term pressures, Merck’s valuation has compressed to remarkably attractive levels. The stock currently trades at just 11.7 times trailing earnings – a substantial discount to both the broader market and its historical average. This compressed multiple provides significant downside protection while investors wait for catalysts to materialize.

Looking forward, Merck has several potential growth drivers that the market appears to be discounting. The company is actively developing a GLP-1 weight loss drug, positioning itself to compete in one of pharmaceuticals’ fastest-growing categories. Additionally, Merck is launching a new formulation of Keytruda, its blockbuster cancer treatment, as part of its strategy to extend the franchise beyond upcoming patent expirations.

For income-focused investors, Merck’s dividend yield has risen to an attractive 4.2% due to the share price decline – providing a meaningful income stream while waiting for potential share price recovery.

Block (XYZ): Fintech Leader at Bargain Basement Pricing

Block stands out as the most severely punished stock on our watchlist, with shares plummeting 34% year-to-date. This dramatic decline followed disappointing quarterly results that triggered additional selling pressure in an already challenging market for fintech names.

The company faces legitimate near-term headwinds, including concerns about consumer spending in a potentially softening economy. Additionally, Block’s significant Bitcoin exposure (representing 40% of revenue) introduces volatility to financial results, as evidenced by a $93 million remeasurement loss in the most recent quarter.

However, looking beyond these headline numbers reveals surprising operational strength. Block’s core operating profit reached $329 million in Q1, representing impressive 32% growth when excluding the Bitcoin-related accounting adjustment. This underlying profitability demonstrates that the company’s fundamental business model continues performing well despite macroeconomic uncertainties.

The market’s pessimism has compressed Block’s valuation to just 12 times trailing earnings and less than 14 times forward earnings estimates – remarkably cheap for a company leveraging multiple secular growth trends. The business continues expanding its ecosystem across merchant services through its point-of-sale solutions and consumer financial services via Cash App.

For investors willing to accept some near-term volatility and cryptocurrency exposure, Block offers an unusually attractive entry point into a fintech leader with substantial growth potential as digital payments continue displacing cash transactions globally.

Alphabet (GOOGL/GOOG): Tech Giant at Value Stock Pricing

Alphabet shares have declined 16% since the beginning of the year, currently trading roughly 10% above their 52-week low. This weakness stems primarily from growing investor concern that antitrust pressures could eventually force a breakup of the technology giant.

Despite these regulatory headwinds, Alphabet’s business fundamentals remain exceptionally strong. The company generated a staggering $112 billion in earnings over the trailing twelve months – massive profitability that the market seems increasingly willing to discount due to uncertainty about the company’s future structure.

This disconnect has created a rare valuation opportunity. Alphabet currently trades at just 17.8 times trailing earnings, significantly below the S&P 500’s average multiple of 23. This represents an unusual discount for a business with dominant positions in search (Google), video (YouTube), mobile operating systems (Android), and emerging competitive positioning in artificial intelligence through its Gemini platform.

While regulatory risks shouldn’t be dismissed entirely, even a potential breakup scenario could ultimately unlock shareholder value by revealing the full worth of Alphabet’s individual business segments. The current consolidated structure potentially masks the true value of high-growth divisions that might command premium multiples as standalone entities.

For investors seeking exposure to artificial intelligence trends at a reasonable valuation, Alphabet offers a compelling combination of established cash flow generators and cutting-edge technology investments. The company’s 0.49% dividend yield, while modest, represents a growing commitment to shareholder returns that supplements its ongoing share repurchase program.

These three companies demonstrate that market overreactions often create opportunities for disciplined investors. While each faces legitimate short-term challenges, their compressed valuations provide attractive entry points for those focused on long-term business fundamentals rather than temporary market sentiment.

Popular Posts

My Favorites

Stock Hotlist: Top Picks to Watch Now

0
Picking the wrong stocks can decimate your portfolio. They're pure portfolio poison.   But the right stocks… If you pick the right stocks, you could find yourself jumping...